Response to “Ipilimumab (Yervoy) and the TGN1412 catastrophe”
Author:
Publisher
Elsevier BV
Subject
Hematology,Immunology,Immunology and Allergy
Reference7 articles.
1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N. Engl. J. Med.,2010
2. Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity;Kocak;Cancer Res.,2006
3. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice;Kolar;Arthritis Rheum.,2009
4. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N. Engl. J. Med.,2011
5. Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma;Sarnaik;Clin. Cancer Res.,2011
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?;Frontiers in Immunology;2024-05-10
2. Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report;Frontiers in Immunology;2024-03-20
3. Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers – a retrospective study of a single institution;Cancer Immunology, Immunotherapy;2020-11-05
4. Exploiting autoimmunity unleashed by low‐dose immune checkpoint blockade to treat advanced cancer;Scandinavian Journal of Immunology;2019-10-07
5. MiStImm: an agent-based simulation tool to study the self-nonself discrimination of the adaptive immune response;Theoretical Biology and Medical Modelling;2019-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3